Abeona Therapeutics Inc reports fiscal Q2 2026 results with non-GAAP EPS $-0.35 (-120% YoY) and revenue $11.4M (+2745% YoY), misses EPS and revenue estimates
https://finviz.com/stock?t=ABEO&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.